Literature DB >> 7706174

Comparison of antibiotic combinations against penicillin-resistant pneumococci.

B Cassinat1, M H Nicolas.   

Abstract

The isolation rate of penicillin resistant pneumococci is increasing in France. To date, cefotaxime and ceftriaxone are the two drugs recommended for the treatment of severe infections and oral third generation cephalosporins are frequently employed for the treatment of non-invasive pneumococcal diseases. In this study, we determined the bacteriostatic activity of 21 antibiotic combinations against 13 clinical isolates of Streptococcus pneumoniae with MICs > or = 0.1 mg/L penicillin and 13 strains that were susceptible.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7706174     DOI： 10.1093/jac/34.5.785

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  3 in total

1.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; H Beloeil; A Pechinot; F Duigou; J C Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

3.  In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.

Authors:  M Pestel; E Martin; C Aucouturier; J F Lemeland; F Caron
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.